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Abstract
Background: There is increasing evidence that cancers contain their own stem-like cells, and particular attention
has been paid to one subset of cancer-stem cells termed side population (SP). Stem cells under normal physical
conditions are tightly controlled by their microenvironment, however, the regulatory role of the microenvironment
surrounding cancer stem cells is not well characterized yet. In this study we found that the phenotype of SP can
be “generated” by macrophage-like cells under conditioned culture. Furthermore the gene regulation pathway
involved in cellular reprogramming process was investigated.
Methods: The selection and identification of SP in 50 CNE-2 single cell clones were performed by flow cytometry.
The transwell assay and immunofluorescence staining were used to measure migration and cancer stem cell
characters of non-SP single clone cells cultured with conditioned medium respectively. The subtraction suppression
hybridization (SSH) technique and northern blotting analysis was applied to explore the pluripotency-associated
genes under a unique epigenetic sub-microenvironment.
Results: Among 50 clones, only one did not possess SP subpopulation while others did. The non-SP cells induced
by macrophage-like cells showed more aggressive characters, which increased cell migration compared with the
control cells and showed some fraction of SP phenotype. These cells expressed distinguished level of pluripotency-
associated genes such as ADP-ribosylation factor-like 6 interacting protein (ARMER), poly (rC) binding protein 1
(PCBP1) and pyruvate dehydrogenase E1-b subunit (PDHB) when subjected to the environment.
Conclusion: To our knowledge, this is the first study to demonstrate that non-SP single-clone cells can be induced
to generate a SP phenotype when they are cultured with conditioned medium of macrophage-like cells, which is
associated with the reactivation of pluripotency-associated genes.
Background
The hypothesis of cancer stem cell (CSC) suggests that
neoplastic clones are maintained exclusively by a small
subpopulation of cells that give rise to phenotypically
diverse cancer cells [1-3]. CSCs were first identified in
1990s in hematological malignancies, mainly acute mye-
logenous leukemia (AML) and also in other subtypes
like AML M0, M1, M2, M4, and M5, chronic myeloid
leukemia (CML), acute lymphoblastic leukemia (ALL),
and multiple myeloma [4,5]. This subset of cancer cells
was also found in solid tumors in the breast, brain, lung,
prostrate, testis, ovary, stomach, colon, skin, liver and
pancreas [6-11]. Thus, there is overwhelming evidence
that certain pathways which regulate or maintain the
extensive proliferative and self-renewal potential of the
tumor clone are present in CSC.
It is known that niches control stem cell function,
thus it may seem counterintuitive that CSCs would be
located within these regulatory microenvironments.
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Since this question was first raised in 2005 [12], soon in
2007 evidence was shown that the vascular niches in
brain tumors are abnormal and contribute directly to
the generation of CSCs and tumor growth [13]. There-
fore, CSCs might arise from normal stem cells that have
acquired mutations that enable them to escape from
niche control. Alternatively, deregulation of extrinsic
factors within the niche might lead to uncontrolled pro-
liferation of stem cells and tumorigenesis [14]. The fate
of CSCs depends upon aberrant niche microenviron-
ments to some extent, thus these niches might represent
targets for the treatment of cancer. We paid particular
attention to the source of CSCs and possible regulatory
pathway in nasopharyngeal carcinoma (NPC) microen-
vironment herein.
NPC is a malignancy of the head and neck region that
arises from the epithelial cells that cover the surface and
line of the nasopharynx. This disease was initially
reported in 1901, and characterized clinically in 1922
[15]. It is endemic in many geographical regions, includ-
ing Southern China and Southeast Asia, where the
observed incidence rates range from 15 to 50 per
100,000 persons. Previous studies have reported that
squamous cell carcinoma (former WHO type 1)
accounts for approximately 25% of all NPC; whereas
undifferentiated carcinoma (former WHO type 3)
accounts for 95% of all cases in high incidence areas
[15-18]. The management of recurrent cervical lymph
node metastases in NPC after radiation and chemother-
apy is a radical surgery of the lymph nodes of the neck
with postoperative brachytherapy. The salvage surgical
procedure for persistent or recurrent neck disease
shows a 5-year control rate of 66% and a 5-year actuar-
ial survival of 38% [18]. Thus, the control of the differ-
entiation and metastases may be the key to
understanding this carcinoma. Our study combining the
NPC CSCs with microenvironment aimed to address
this key question.
Some markers and phenotype of CSCs were similar to
that of normal neural stem cells. For example, they
express CD133 and nestin in brain cancer, CD44 in
breast cancer and CD34 in leukemia [4,5,7,8]. Recent
evidences demonstrate that ABCG5 and USP22 may be
used as cancer stem cell marker [19,20]. On the other
hand, a character of stem cells termed side population
(SP) can be identified due to the cellular exclusion of
Hoechst 33342 dye. The SP cells have been isolated by
flow cytometric analysis from various types of adult
tumor tissue where they possess stem cell activity,
including lung adenocarcinoma, gastrointestinal cancers,
head and neck squamous cell carcinoma, ovarian cancer,
thyroid cancer, and hepatocellular carcinoma [21-27].
Here, we performed our work on human NPC CNE-2
cells, of which SP phenotype revealed several stem cell
properties [28], to investigate whether NPC CSCs are
tightly regulated by the immediate microenvironment,
to evaluate the differential gene expression profile of the
CSCs with microenvironment, and to find more specific
stem cell marker for NPC CSCs.
In this study, we tried to identify cancer non-SP cell
clone from human NPC cancer cell line CNE-2. Such
non-SP cell clone was isolated and cultured with macro-
phage-like cells. We found that conditioned culture
could induce generation of SP cells by the non-SP cells
derived from both NPC and neuroblastoma cell lines.
Moreover, we evaluated the cell cycle and migration
ability of condition cultured non-SP cells, which cells
showed G1/S arrest and enhanced motility compared
with control. We further identified the differential gene
profile in condition cultured non-SP cells by the sub-
traction suppression hybridization (SSH).
Methods
Cell lines and reagents
Human acute monocytic leukemia cell line THP-1,
human nasopharyngeal cancer cell line CNE-2 and
human neuroblastoma cell line SK-N-CH were obtained
from American Tissue Culture Collection (Rockville,
MD, USA).
Antibodies including CD133 and CD133-PE were pur-
chased from Miltenyi Biotech (Bergisch Gladbach, Ger-
many). All the other reagents were purchased from
Sigma (St Louis, MO, USA) unless otherwise noted.
Single clone selection
Cells were seeded in a 24-well plate with 1 cell/ml and
single cell clones were isolated from wells with only a
solitary colony. Selecting 50 single cell clones were sub-
jected to expansion culture until sufficient amounts of
cells were obtained. The 50 single cell clones were
detected by the flow cytometric analysis of SP and non-
SP distribution respectively. One CNE-2 single clone is
named CNE-2-2 with little SP phenotype.
Macrophage-conditioned medium
THP-1 cells at a density of 0.5 × 106/ml were cultured
in RPMI 1640 (Invitrogen, San Diego, CA, USA) supple-
mented with 10% FBS (Hyclone, Logan, UT, USA) and
20 ng/ml phorbol 12-myristate 13-acetate (PMA) for 48
h at 37°C in a humidified atmosphere of 5% CO2 incu-
bator. After nonadherent cells were discarded, remaining
cells were washed twice in PBS and once in RPMI 1640
with 15-min incubation at 37°C. These PMA induced
macrophage-like cells were cultivated for 24 h with
fresh RPMI 1640 containing 10% FBS (8 ml per 75-cm3
flask). The supernatant after culture was subsequently
filtered and used as the macrophage-conditioned
medium.
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Cell culture
NPC Cells were cultured in a 25-cm2 tissue culture flask
(1.2 × 104cells/cm2) in RPMI 1640 supplemented with
10% FBS, 50 U/ml penicillin and 50 μg/ml streptomycin
for 24 h. Cells were washed with PBS and the condi-
tioned medium produced by PMA-activated THP-1 cells
was added. After indicated cultivation days, nonadherent
cells were gently washed away with PBS and adherent
cells were harvested with 0.05% trypsin-EDTA for test.
Flow cytometry
To identify the SP cells in the cancer cells, we selected
the single clone cells as described above. The cells were
removed from the culture dish with trypsin/EDTA (Invi-
trogen) and resuspended at 10 cells per ml RPMI 1640
supplemented with 2% FBS, 50 U/ml penicillin and 50
μg/ml streptomycin. Cells were preincubated in a 1.5-ml
Eppendorf tube for 90 min at 37°C with 2.5 μg/ml
Hoechst 33342 dye (Invitrogen), either alone or in com-
bination with 50 M verapamil, an inhibitor of some ver-
apamil-sensitive ABC transporters [29]. Finally, the cells
were counterstained with 1 μg/ml propidium iodide to
label dead cells. Cells were analyzed in a FACSVantage
fluorescence-activated cell sorter (Becton Dickinson).
Propidium iodide-positive dead cells (<15%) were
excluded from the analysis.
The non-SP Cells from the single clone detected by
FACS were seeded into a 6-well plate at 1 × 105 cells/
well and incubated with conditioned medium at 37°C.
After 24 h of incubation, cells were collected with tryp-
sin/EDTA. SK-N-CH cells were incubated with CD133-
PE antibody for 10 minutes at 4°C before FACS analysis.
CNE-2-2 single-cell suspension was fixed in ice-cold 70%
ethanol at -20°C for 16 h, labeled with propidium iodide
(50 μg/ml) for at least 15 min in dark and analyzed
directly on a FACSCalibur flow cytometer (Becton Dick-
inson Immunocytometry Systems, San Jose, CA, USA).
Immunofluorescence staining
Cells grown on cover slips were washed in cold PBS and
fixed in 2% paraformaldehyde-PBS for 20 min and per-
meabilized in 0.5% Triton X-100 in PBS for 10 min at 4°C.
The cells were incubated with 1% BSA for 30 min at room
temperature (RT) to block nonspecific binding before the
primary antibody reaction. Cells were incubated with the
primary antibodies to CD133 for 1 h at RT, and then a
specific FITC conjugated secondary antibody for 1 h. Cells
were counterstained with DAPI (1 μg/μl), and examined
using a fluorescence microscope (Olympus BX51).
Transwell migration assay
CNE-2-2 cells were starved overnight in assay media
(RPMI 1640 with 1% FBS). The top chamber of a 24-
well transwell plate (Corning Inc.) was pretreated with
1% Matrigel™ (BD Biosciences, San Jose, CA, USA) in
PBS and incubated 1 h at RT. Cells (105/ml) were added
to the top chambers of the plates. Media with or with-
out activated macrophage-like cells was added to both
chambers. After overnight incubation, top cells were
removed and bottom cells were fixed and stained with
DAPI (5 μg/ml) to visualize nuclei. The number of
migrating cells in five fields was counted under fluores-
cence microscope, and the mean for each chamber was
determined.
Nucleic acid preparation
All of the cells were snap-frozen in liquid nitrogen and
stored at -80°C. The tested cells were lysed in Trizol
Reagent (Invitrogen, CA, USA), and total RNA was iso-
lated according to the manufacturer’s instructions.
mRNA of the conditioned culture non-SP single cell
clone and non-conditioned culture cells was purified
from total RNA using the Oligotex mRNA Spin-Column
kit (Qiagen, Hilden, Germany).
Suppression subtractive hybridization (SSH)
SSH was performed between conditioned culture non-
SP single cell clone and non-conditioned culture cells
using the PCR-Select cDNA Subtraction Kit (Clontech,
Palo Alto, CA) according to the manufacturer’s recom-
mendations. In the subtraction, conditioned culture
non-SP single clone cells were used as a tester and non-
conditioned culture single clone cells were used as a dri-
ver. Double-strand cDNA was synthesized from poly
(A)+ RNA and blunted according to the kit manual.
Two tester populations were created with different
adaptors, but no adaptors with the driver.
After two cycles of hybridization, we carried out 28
cycles of primary PCR and 21 cycles of secondary PCR
with DNA polymerase (Promega, Madison, WI, USA)
on a GeneAmp 2400 thermal cycler (PE Biosystems,
Foster City, CA, USA). To evaluate the efficiency of
cDNA subtraction, we compared the expression of
human b-actin (NP_001092) using the primers as
denoted on Table 1 in subtracted and unsubtracted PCR
products respectively. The subtracted fragments were
then inserted into the T/A cloning vector pCR 2.1-
TOPO (Invitrogen, CA, USA).
Differential Screening
120 individual recombinant clones were picked and used
as templates for PCR amplification using vector primers
M13F and M13R. Each PCR product (about 1 μl) was
transferred to a nylon membrane (Hybond-N, Amer-
sham Pharamacia Biotech, Uppsala, Sweden). For dena-
turing purposes, the membrane was submerged for 2 - 3
min in turn on the three pieces of Whatman 3 MM
paper saturated with 1.5 M NaCl and 0.5 M NaOH, 1.5
Cao et al. BMC Cancer 2010, 10:68
http://www.biomedcentral.com/1471-2407/10/68
Page 3 of 11
M NaCl and 0.5 M Tris-HCl (pH 8.0), 0.2 M Tris-HCl
(pH 7.5) and 2 × SSC buffer, respectively. Subtracted
and unsubtracted PCR products were used as probes
labeling with digoxigenin-dUTP at 37°C overnight
according to the DIG High Prime Labeling Kit protocol
(Roche Molecular Biochemicals, Mannheim, Germany).
The dot blot hybridization was performed overnight at
42°C using the DIG Easy Hyb system (Roche Molecular
Biochemicals, Mannheim, Germany) following the man-
ufacturer’s instructions. The blots were washed at RT
twice at low stringency (2 × SSC, 0.1% SDS) for 5 min
and then at 68°C twice at high stringency (0.1 × SSC,
0.1% SDS) for 15 min. Hybridized probes were subse-
quently detected by alkaline phosphatase-conjugated
anti-DIG antibody and the CSPD chemiluminescent
detection system (Roche Molecular Biochemicals, Man-
nheim, Germany).
Sequencing and Sequence analysis
Nucleotide sequences were compared with the GenBank
using the BLASTn programs from the National Center
for Biotechnology Information http://www.ncbi.nlm.nih.
gov/BLAST/ and the BLASTx for the protein. Protein
patterns were then identified by searching the PROSITE
database http://www.expasy.ch/tools/ and Pfam database
http://pfam.sanger.ac.uk/.
The DNA was sequenced from both strands on an
ABI PRISM 377 Genetic Analyzer (PE Biosystems, Fos-
ter City, CA, USA).
Northern blotting analysis
Digoxigenin-labelled DNA probes were applied for
Northern blotting analysis. Oligonucleotide primers for
the DNA probes were designed based on the known
sequences (Table 1). The programs were as follows: 94°
C for 5 min, followed by 35 cycles of 30 sec at 94°C, 30
sec at 56°C, and 90 sec at 72°C, and a final polymeriza-
tion step at 72°C for 10 min, and then the PCR products
were purified using QIAquick PCR Purification Kit
(Qiagen, Hilden, Germany). The fragments were labeled
with digoxigenin-dUTP as above.
Each set of total RNA was extracted from conditioned
culture non-SP single clone cells and non-conditioned
culture single clone cells described above. Total RNA
was quantified on a spectrophotometer at 260 nm. Ali-
quots containing 10 μg of total RNA corresponding to
each tissue were mixed with glyoxal and DMSO and
heated at 50°C for 30 min and then placed on ice over 1
min. The treated RNAs were then separated through a
1% agarose (Seakem) gel. The intensity of ethidium bro-
mide-stained rRNA bands was examined visually to
ensure that equal amounts of total RNA were loaded
onto the gels. The RNA was then transferred to a nylon
membrane (Hybond-N, Amersham Pharamacia Biotech,
Uppsala, Sweden), and UV cross-linked. Hybridization
was performed overnight at 50°C, washed at RT twice at
low stringency for 5 min and then at 55°C twice at high
stringency for 15 min and were detected as above.
Results
Identification of SP cells in the CNE-2 single clones
To determine whether different percentages of SP cells
were contained in CNE-2 cells, we screened the CNE-2
cells by single clone selection. We stained the single
clone cells respectively with Hoechst 33342, which is
actively extruded by verapamil-sensitive ABC transpor-
ters. The SP cells from representative single clone CNE-
2 ranged from 0.1% to 73.7% as estimated by FACS ana-
lysis (Fig. 1A, B and 1C). In each case, by definition, the
number of SP cells was decreased greatly by treatment
with verapamil (Fig. 1 bottom panel). We could detect
little SP cells in just a single clone cell (Fig. 1C, clone
2). Thus, most of the CNE-2 cancer cell clones con-
tained a small or big component of SP cells. Our study
is focus on whether microenvironment might have an
effect on the percentage of SP cell in CNE-2, i.e,
whether it play a role in the cancer stem cell pool, so
the further experiments were mainly performed the
human CNE-2 single clone (namely CNE-2-2) with little
SP phenotype.
We cultured the CNE-2-2 clone with conditioned
medium and carried out FACS analysis for the presence
of SP. As shown in Fig. 1D, the CNE-2-2 cell clone con-
tained 9.8% SP cells after cultured with macrophage-like
cells, whereas the control CNE-2-2 cells only contained
0.1% SP. The data therefore suggested that macrophage
might be responsible for maintaining the CNE-2 cancer
stem cell pool.
Validation SP alteration in neuroblastoma SK-N-CH cells
To further confirm the above phenomena, we selected
another cell line, the human neuroblastoma cell line SK-
N-CH in which we could barely detect the presence of
Table 1 Northern blot probe primers
Gene symbol Primer sequence
ARMER F-primer CGGAGGGAGATAATCGCAGCACCAAC
R-primer GAAGCAGGTTGTGGACTTGTTGTCCC
PCBP1 F-primer CGCCGGAATTGACTCCAGCTCTCC
R-primer CAGAAAGGGGTTATTGAGGGAACCTAC
PDHB F-primer CGGTGTCTGGCTTGGTGCGGAGAC
R-primer GAGTTTATAACCTGGTCAATGGCTTGC
FUBI F-primer TTTCAGATTCTAGAGTTATGTCCTC
R-primer ATAGAATGGGATGCTGTCTGGGAA
b-actin F-primer CGCGCTCGTCGTCGACAACGGC
R-primer CGTACATGGCTGGGGTGTTGAAGGTC
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SP and the expression of CD133, one of the markers of
neuroblastoma cancer stem cells. After cultured with
activated macrophage medium, SK-N-CH cells were
stained with CD133 antibody for FACS analyses. As
shown in Fig. 2A, the condition cultured SK-N-CH cells
contained 4.5% cancer stem cells, whereas the control
SK-N-CH cells only contained 0.6%.
Furthermore, we examined the expression of CD133
on SK-N-CH cells in response to the conditioned cul-
ture induced by macrophage-like cells with immuno-
fluorescence. The fluorescence density of CD133
positive cells was evidently stronger than that in con-
trol (Fig. 2B). These results allowed us to conclude
that human macrophages did play a role in maintain-
ing cancer stem cell pool at least in several solid
tumors.
G1-S cell cycle and migration of CNE-2 single clone cell
affected by conditioned culture
Next, we analyzed cell cycle distribution in CNE-2-2
cells with conditioned medium. Cell cycle profiling of
CNE-2-2 cells revealed that the conditioned culture
induced reduction of the G1-S transition at 24 hours
(Fig. 3A and 3B). By contrast, Control experiments
showed no cell growth arrest features at 24 hours.
Following culture with activated macrophage-like cells,
derived from human THP-1 cells, in a Transwell Boyden
chamber system without cell-to-cell contact, CNE-2-2
cells resulted in a robust increase (>4 folds) in cell moti-
lity after 18 hours, whereas in control the normal cul-
ture conditions did not enhance the migration ability of
CNE-2-2 cells (Fig. 3C and 3D). Taken together, these
results clearly indicated that the functional components
in macrophage-like cells responsible for cancer stem cell
were complicated.
Differential gene expression profile of conditioned
culture CNE-2 single clone cell
The SP pool expansion, G1/S arrest and migration
improvement in CNE-2-2 cells described above implied
the cancer stem cell change in the cultured environment
provided by macrophage-like cells. We further deter-
mined gene pathways involved during this process and
studied the differential gene expression profiles between
condition cultured and non-condition cultured CNE-2-2
cells by substractive suppression hybridization (SSH).
About 120 clones were obtained from the SSH library
enriched for the conditioned cultured CNE-2-2 cells
transcripts. Following PCR using vector primers M13F
and M13R and DNA dot-blot screening, 45 clones exhi-
biting expression differences were selected for DNA
sequence analysis, which included 5 up-regulated (fold
change >2) and 40 up-regulated (fold change >1.2)
genes (Table 2).
Figure 1 FACS analysis of side population (SP) in the CNE-2 cell line labeled with Hoechst 33342. (A and B) SP cells exist in CNE-2 single
clone cells at a various percentage; (C) One clone contains little SP cell; (D) SP cells are increased by cultured with macrophage-like cells. The
bottom panel shows the reduction of SP after treatment with 50 μM of verapamil. The data are representative of experiments over three times
with similar results.
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Figure 2 Validation of SP cell fraction increase by cultured with macrophage-like cells in human neuroblastoma cell line SK-N-CH.
(A) Conditioned culture SK-N-CH cells show higher percentage of the CD133-PE population by FACS. (B) Immunofluorescence staining confirms
the higher expression of CD133 (green). The images shown are representative of cells after cultivation for 24 hours. Nuclei were counterstained
with DAPI (blue). Original magnification ×600.
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The SSH data was further validated by Northern blot-
ting analysis. Results revealed that mRNAs of ADP-ribo-
sylation factor-like 6 interacting protein (ARMER), poly
(rC) binding protein 1 (PCBP1) and pyruvate dehydro-
genase E1-b subunit (PDHB) were only expressed in
conditioned culture CNE-2-2 (Fig. 4A, B and 4C), and
the level of ubiquitin-like protein fubi and ribosomal
protein S30 precursor (FUBI) mRNA transcript was
higher in conditioned cultured cells compared with con-
trol (Fig. 4D).
Discussion
In this study we have identified the non-SP cell clone in
CNE-2 cells and found that conditioned culture non-SP
cells were able to generate SP phenotype when microen-
vironment were present. Non-SP cells cultured with
macrophage-like cells could not only produce
heterologous descendent cells but also showed cell cycle
arrest and higher cell motility. Furthermore we have
determined the gene pathway involved during these pro-
cesses by the SSH. To our knowledge, this is the first
report to demonstrate the correlationship between non-
SP cells and microenvironment in a tumor.
The impetus to CSC-theory has been only recently pro-
posed due to the advances in stem cell biology although
the concept of CSCs is not new. We showed here for the
first time that non-SP cancer cells cultured with macro-
phage-like cells were able to generate SP phenotype
probably by asymmetric division or reprogramming. In
addition, by using different cell line (SK-N-CH) and can-
cer stem cell marker CD133, we have observed the con-
sistent phenomena. It has been reported that brain CSCs
are maintained within vascular niches [13]. Here we pro-
vided evidences that CSCs depended upon aberrant
Figure 3 Activated macrophage-like cells’ medium inhibits G1-S transition and enhances migration in CNE-2 single clone cells. (A) Cell
cycle distribution of CNE-2 single clone cells after cultivation for 24 hours. (B) Percentage of G1, S and G2-M phases in CNE-2 single clone cells.
Values are means ± SD (n = 3). * P < 0.01 vs control. (C) The migration of the CNE-2 single clone cells is enhanced by conditioned culture for
18 h in a transwell apparatus. Images shown are representative of three independent experiments. Nuclei were labeled with DAPI (blue), original
magnification ×200. (D) Migration level is shown by quantified the migrated cells in 10 random fields per filter. Values are means ± SD (n = 3).
*** P < 0.001 vs control.
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niche microenvironments indeed, hence these niches
might represent targets for treatments of cancer. Further
understanding of the fate of cancer stem cells interfered
by their particular microenvironment may bring out a
new era for cancer treatment.
A cancer stem cell is thought to be quiescent and should
be in G0/G1 phase [30]. Non-SP cells cultured with
macrophage-like cells could be arrested on G1/S thus slow
down the cell cycle. It therefore indicated that the micro-
environment had an effect on cell-cycle-specific change.
On the other hand, the migration of the non-SP cells is
enhanced through conditioned culture. Therefore, these
results implied that non-SP cells showed more aggressive
characteristics with response to microenvironment.
Comprehensive analysis of gene expression using SSH
revealed distinct differences between conditioned culture
and non-conditioned culture cells. A few genes have
been found to be evidently up-regulated in conditioned
cultured non-SP cells. Genes such as ARMER, PCBP1
and PDHB were only expressed in conditioned cultured
non-SP cells, which can be validated by Northern blot-
ting analysis. ARMER is an apoptotic regulator in the
Table 2 Categories of altered genes in CNE-2 single clone cells by macrophages-like cells during conditioned culture
Accession No. Gene description Alteration
NM_001012 Ribosomes This gene encodes a ribosomal protein that is a component of the 40S subunit. Up
NM_002140.2 heterogeneous nuclear ribonucleoproteins (hnRNPs) Up
NM_005174.2 Homo sapiens ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (ATP5C1), nuclear
gene encoding mitochondrial protein, transcript variant 2, mRNA
Up
NM_015937.3 Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class T (PIGT), mRNA Up
NM_018085.4 Homo sapiens importin 9 (IPO9) Up
NM_000314.4 Homo sapiens phosphatase and tensin homolog (PTEN) Up
NM_001033756.1 Homo sapiens vascular endothelial growth factor A (VEGFA), transcript variant 7, mRNA Up
NM_003064.2 Homo sapiens secretory leukocyte peptidase inhibitor (SLPI) Up
NM_002394.4 Homo sapiens solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2),
transcript variant 3
Up
NM_005496.3 Homo sapiens structural maintenance of chromosomes 4 (SMC4), transcript variant 1 Up
NM_006145.1 Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1) Up
NM_002306.2 Homo sapiens lectin, galactoside-binding, soluble, 3 (LGALS3), transcript variant 1 Up
NM_020186.1 Homo sapiens ACN9 homolog (S. cerevisiae) (ACN9) Up
NM_005347.2 Homo sapiens heat shock 70 kDa protein 5 (glucose-regulated protein,78 kDa) (HSPA5) Up
NM_016639.1 Homo sapiens tumor necrosis factor receptor superfamily, member 12A (TNFRSF12A) Up
NM_005348.3 Homo sapiens heat shock protein 90 kDa alpha (cytosolic), class A member 1 (HSP90AA1), transcript variant 2 Up
NM_194247.2 Homo sapiens heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3) Up
NM_004148.3 Homo sapiens ninjurin 1 (NINJ1) Up
NM_002337.1 Homo sapiens low density lipoprotein receptor-related protein associated protein 1 (LRPAP1) Up
NM_001003703.1 Homo sapiens ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 (ATP5J), nuclear gene encoding
mitochondrial protein, transcript variant 1
Up
NM_004048.2 Homo sapiens beta-2-microglobulin (B2M) Up
NM_000146.3 Homo sapiens ferritin, light polypeptide (FTL) Up
NM_001105079.1 Homo sapiens fibrosin (FBRS), mRNA Up
NM_001002.3 Homo sapiens ribosomal protein, large, P0 (RPLP0) transcript variant 1 Up
NM_015134.2 Homo sapiens myosin phosphatase Rho interacting protein (MPRIP), transcript variant 1 Up
NM_004888.3 Homo sapiens ATPase, H+ transporting, lysosomal 13 kDa, V1 subunit G1 (ATP6V1G1) Up
NM_015161.1 Homo sapiens ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1) Up
NM_001001973.1 Homo sapiens ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (ATP5C1), nuclear
gene encoding mitochondrial protein, transcript variant 1
Up
NM_001997.3 Homo sapiens Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (FAU) Up
NM_006196.2 Homo sapiens poly(rC) binding protein 1 (PCBP1) Up
NM_000925.2 Homo sapiens pyruvate dehydrogenase (lipoamide) beta (PDHB) Up
NR_003286.1 Homo sapiens 18S ribosomal RNA (LOC100008588) Up
BAG64005.1 unnamed protein product Up
NW_001838014.1 Homo sapiens chromosome 10 genomic contig, alternate assembly Up
NT_007592.14 Homo sapiens chromosome 6 genomic contig, reference assembly Up
NW_001839064.2 Homo sapiens chromosome 7 genomic contig, alternate assembly Up
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membrane of the endoplasmic reticulum [31], and was
one of the most intensely up-regulated gene when cul-
tured with the differentiated THP-1 conditioned media.
Figure 3 reveals a large amount of apoptotic cells in the
control and proportionally less in the conditioned cul-
ture population. Thus, the possible anti-apoptotic effect
of ARMER may be induced when cultured with the con-
ditioned medium. While PCBP1 plays a role in the pro-
tein-protein interaction network for human inherited
ataxias and disorders of Purkinje cell degeneration [32].
PDHB is involved in tricarboxylic acid cycle of fibroblast
[33]. We also found that FUBI mRNA transcript level
was increased in conditioned cultured cells compared
with control. Overexpression of FUBI leads to cell
death, which can be halted by Bcl-2 or inhibition of cas-
pases [29,34]. We have tried to compare our gene pro-
file data with those of similar study on hepatocellular
carcinoma, thyroid cancer and lung adenocarcinoma,
but they are not in the same pattern suggesting the het-
erogenic nature of different malignancies. None of the
up-regulated genes in non-SP cells found here have
been documented to be involved in NPC. This might be
partly explained by the different characteristics of non-
SP cells and SP cells. The abundance of SP in CSCs
from the same tumor contributes to distinct gene
expression patterns, which has been often neglected by
previous studies for many years.
Conclusion
We have identified, for the first time, non-SP single
clone cells can generate SP phenotype when they are
cultured with macrophage-like cells. It should be noted
that non-SP single clone cells derived directly from NPC
CNE-2 cells would like to maintain non-SP characters,
whereas non-SP cells sorted with FACS were inclined to
gain SP. The underneath mechanism of the interesting
phenomena is far yet clear. Further studies are needed
to further pin-point the original source of the cancer
stem cell in NPC and apply it for establishment a novel
therapy of this malignancy.
Figure 4 Northern blotting analysis of SSH data. Conditioned culture CNE-2 single clone cells show detectable higher mRNA transcription of
ARMER (A), PCBP1 (B), PDHB (C) and FUBI (D) compared with control. The ethidium bromide-stained 28S/18S rRNA bands were used as a
control for loading variation.
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